GEOVAX Story

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;'>GL</div>
GOVX -- USA Stock  

USD 4.60  0.42  8.37%

It appears GEOVAX LABS will continue to recover much faster as its share price surged up 62.42% today. The firm current daily volatility is 14.16 percent, with a beta of -1.86 and an alpha of 0.99 over DOW. As many baby boomers are still indifferent towards business services, it makes sense to break down GEOVAX LABS INC. We will look into some reasons why it is still possible for GEOVAX LABS to maintain above-average margins while minimizing volatility.
Published over a week ago
View all stories for GEOVAX LABS | View All Stories
Will the current GEOVAX LABS volatility rise frighten investors?
GEOVAX LABS INC currently holds roughly 11.58 M in cash with (1.49 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.25. GEOVAX LABS INC currently holds 201.09 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest GEOVAX LABS is not taking enough advantage from borrowing. The entity has a current ratio of 12.45, suggesting that it is liquid enough and is able to pay its financial obligations when due.
Investing in GEOVAX LABS, just like investing in any other equity instrument, is characterized by a strong risk-return correlation. High risks mean high returns and low risk means lower expected returns. Risk management is the act of identifying and assessing the potential risk and developing strategies to minimize these risks and earn maximum possible profits while holding GEOVAX LABS along with other instruments in the same portfolio. Using conventional technical analysis and fundamental analysis to select individual securities into a portfolio complements risk management and adds value to overall investors' investing strategies.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of GEOVAX LABS's stock price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of GEOVAX LABS in the context of predictive analytics.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as GEOVAX LABS. Your research has to be compared to or analyzed against GEOVAX LABS's peers to derive any actionable benefits. When done correctly, GEOVAX LABS's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in GEOVAX LABS INC.

How important is GEOVAX LABS's Liquidity

GEOVAX LABS financial leverage refers to using borrowed capital as a funding source to finance GEOVAX LABS INC ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. GEOVAX LABS financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between GEOVAX LABS's total debt and its cash.

How GEOVAX utilizes its cash?

To perform a cash flow analysis of GEOVAX LABS, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash GEOVAX LABS is receiving and how much cash it distributes out in a given period. The GEOVAX LABS cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. GEOVAX LABS Net Cash Flow from Operations is fairly stable at the moment as compared to the past year. GEOVAX LABS reported Net Cash Flow from Operations of (1.61 Million) in 2020

GEOVAX LABS Correlation with Peers

Investors in GEOVAX can reduce exposure to individual asset risk by holding a diversified portfolio of assets in addition to a long position in GEOVAX LABS INC. Diversification will allow for the same portfolio return with reduced risk. The correlation table of GEOVAX LABS and its peers is a two-dimensional matrix that shows the correlation coefficient between pairs of securities GEOVAX is related in some way. The cells in the table are color-coded to highlight significantly positive and negative relationships. Each cell shows the correlation between one pair of equities and can be used to run pair trading strategies or create efficient portfolios with your current brokerage. Please check volatility of GEOVAX for more details

Purchase by Dean Kollintzas of 11987 shares of GEOVAX LABS

Legal trades by GEOVAX LABS insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
GEOVAX insider trading alert for perchase of common stock purchase warrant by Dean Kollintzas, the corporate stakeholder, on 29th of September 2020. This event was filed by Geovax Labs Inc with SEC on 2020-09-29. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Breaking down GEOVAX LABS Indicators

GEOVAX LABS is dangerous given 1 month investment horizon. GEOVAX LABS INC holds Efficiency (Sharpe) Ratio of 0.12, which attests that the entity had 0.12% of return per unit of volatility over the last month. Our viewpoint regarding determining the risk of a stock is to use both market data as well as company specific technical data. We were able to analyze twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.71% are justified by taking the suggested risk. Use GEOVAX LABS INC market risk adjusted performance of (0.35), and Risk Adjusted Performance of 0.0456 to evaluate company specific risk that cannot be diversified away.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Our take on today GEOVAX LABS rise

The jensen alpha is down to 0.99 as of today. GEOVAX LABS INC is displaying above-average volatility over the selected time horizon. Investors should scrutinize GEOVAX LABS INC independently to ensure intended market timing strategies are aligned with expectations about GEOVAX LABS volatility.

Our Final Take On GEOVAX LABS

While other companies within the biotechnology industry are still a little expensive, even after the recent corrections, GEOVAX LABS may offer a potential longer-term growth to investors. To sum up, as of the 11th of January 2021, our present 30 days Buy-Hold-Sell recommendation on the company is Cautious Hold. We believe GEOVAX LABS is undervalued with below average odds of distress for the next two years.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of GEOVAX LABS INC. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com